Methods

Study Population
This study included elderly individuals (age ≥ 65 years) who underwent a health examination since March 2009 to November 2009 at one medical center in Taipei City. A total of 1799 elderly individuals received physical examinations in the hospitals. Data were collected using a questionnaire completed by the interviewer in a face-to-face session in order to avoid write-in errors. After 420 cases were excluded due to incomplete questionnaires, a total of 1379 cases were included for data analysis. Another 198 cases were eliminated, due to incomplete data on the 5 risk factors of MetS. In the end, a total of 1181 complete data sets (recovery rate of 85.6%) were used. All subjects provided written informed consent approved by the Institutional Review Board of our hospital, and the study was issued the project research number 09MMHISO11.
Data Collection
During the visit, a 12 h fasting blood draw was collected, sitting blood pressure (BP) and anthropometric measurements were made. After the participant had sat and rested for 5 -10 min, BP readings were taken twice in the right arm 30 seconds apart. If the first two BP readings differed by more than 10 mmHg, a third BP measurement was made. The average of the two closest readings was calculated and used in the analysis [23] . Waist circumference was measured at the standard point at the end of a relaxed expiration with a tape measure placed parallel to the floor with the participants standing arms outstretched [24] . Plasma sample was collected for analysis of fasting plasma glucose (FPG), and serum was collected for lipid measurements. Fasting total cholesterol, triglyceride (TG), and FPG were measured by an automated system (Vitros 550/750, Ortho-Clinical Diagnostics Inc., a Johnson and Johnson Company, Rochester, NY, USA). Electrophoresis was performed to measure highdensity lipoprotein cholesterol (HDL-C). 
Diagnostic Criteria for MetS
Modified NCEP-ATPIII criteria were used in this study. MetS was defined as the presence of any 3 of the following 5 conditions: abdominal obesity (AO; waist circumference, ≥90 cm for men and ≥80 cm for women), hyper triglyceremia (HTG; TG, ≥150 mg/dl), low serum HDL-C (HDL-C, ≤40 mg/dl for men and ≤50 mg/dl for women), hypertension (HT; systolic BP, ≥130, diastolic BP, ≥85 mmHg, or the use of antihypertensive agents), and hyperglycemia (HG; FPG, ≥100 mg/dl or the use of anti-hyperglycemic agents) [22] .
Insomnia Symptoms/Insomnia Syndrome
The CAIS (Chinese version of the Athens Insomnia Scale) is a self-report instrument designed to screen for insomnia symptoms that occur with a frequency of ≥3 times per week, which were experienced in the past month and are associated with the diagnostic criteria for primary insomnia. CAIS-5 demonstrated the items 1-5 of the AIS (nighttime symptoms) are fair tools for screening and diagnosing insomnia in clinical practice, and they have satisfactory reliability and validity. Responses were rated on a scale from 0 to 3, the score ≥ 2 was included in our study. Correlation coefficients of test-retest reliability were 0.84 -0.86. The suggested cutoff points for insomnia among this ethnic Chinese population are 5 for the CAIS-5 (area under the curve [AUC] = 0.90, p < 0.01) [21] . The presence of insomnia symptoms, included at least 1 insomnia-related sleep complaint (difficulty falling asleep, difficulty staying asleep, sleep is not refreshing, or frequent waking from sleep or dreamy), with a frequency criteria of ≥3 times per week. The insomnia duration was divided into five groups: <1 month, 1 month -1/2 year, 1/2 year -1 year, 1 -3 years, and >3 years.
Brief Symptom Rating Scale
Mental health was screened using the Brief Symptom Rating Scale (BSRS-5). This self-rated questionnaire requires respondents to report whether they had felt tense, blue, irritated, inferior, or had trouble falling asleep in the past week. Responses were rated on a scale from 0 to 4, with 0 being "not at all" and 4 being "extremely." Total scores ranged from 0 to 20 [25] [26] .
Internal consistency (Cronbach's α) coefficients of the BSRS-5 were 0.77 -0.90. The test-retest reliability coefficient was 0.82. When a score of ≥6 was used as the cut-off score for psychiatric casec, the rate of accurate classification of the BSRS-5 was 76.3% (78.9% sensitivity, 74.3% specificity, 69.9% positive predictive value, 82.3% negative predictive value) [25] .
Other Covariates
Other demographic histories, including sex, education level, and living conditions, were collected at this visit. Education level was classified as 1 of the following 5 levels: illiterate, elementary school, junior high school, senior high school, and college or higher; living condition was defined as single or living with family.
Physical activity was assessed by the Lipids Research Clinics Questionnaire and analyzed as a categorical variable (sedentary versus non-sedentary lifestyle) [27] . Other lifestyle characteristics, including smoking history (current or former smoker versus never a smoker) and alcohol consumption (>4 drinks per week versus ≤4 drinks per week) were measured by study-specific questionnaires (MetS and insomnia, sleep).
Statistical Methods SAS 9.0 software (SAS Inc., Cary, NC, USA) and SPSS 17.0 (SPSS Inc., Chicago, IL, USA) were used for statistical analysis. Continuous variables are reported as mean ± standard deviation (SD), and categorical variables are reported as number and percentage. Differences in baseline demographic, psychosocial, lifestyle characteristics, and sleep measures were compared between those who had metabolic syndrome versus those who did not by use of χ 2 tests for categorical variables and student t-tests for continuous variables. Multivariate logistic regression was used to examine the relationship between individual sleep symptoms or insomnia syndrome and the risk of the metabolic syndrome, with adjustment for covariates including age, sex, living status, smoking status, alcohol consumption, sedentary lifestyle, and depression status. The relationships among sleep symptoms and the individual components of metabolic syndrome were analysed. 
Results
Out of the participants, 34.3% (n = 1181) met the criteria of metabolic syndrome. As shown in Table 1 , the percentage of females with MetS was more than the percentage of males (p < 0.01). The mean age of MetS participants was older than that of non-MetS participants. The other factors, including smoking status, alcohol consumption, sedentary lifestyle, living status, and depression status were not significantly different in two groups.
Of the sleep symptoms, only difficulty falling asleep (DFA) had a higher prevalence in MetS participants compared to non-MetS participants (p = 0.01) ( Table 2) . Insomnia syndrome, combined insomnia symptoms, and insomnia duration were not correlated with the occurrence of metabolic syndrome. In the multivariate logistic regression models (Table 3) , which accounted for each of the insomnia symptoms or insomnia duration (adjusted for age, sex, living status, smoking status, alcohol consumption, sedentary lifestyle, and depression status). DFA significantly increase the risk of MetS (OR = 1.42, 95% CI: 1.09 -1.86, P = 0.01). The remaining insomnia symptoms and the syndromic definition of insomnia were unrelated to the risk of the MetS. Table 4 showed that analyses of the individual metabolic syndrome components revealed that DFA and frequent waking from sleep or dreamy increased the risk of abdominal obesity (DFA: OR = 1.36, 95% CI: 1.05 -1.76; frequent awaking: OR = 1.68, 95% CI:1.14 -2.49), and DFA increased the risk of hyperglycemia and high triglycerides (OR = 1.43, 95% CI: 1.01 -1.82; OR = 1.67, 95% CI: 1.23 -2.25); and difficulty staying sleep increased the risk of hypertension (OR = 1.39, 95% CI: 1.14 -1.90). Another insomnia symptoms (non-refreshing sleep) did not increase any of the individual metabolic abnormalities. In this model, we had adjusted for the covariates, including: age, sex, living status (with family/single), smoking status (current or past/never), alcohol consumption (0 -3 drinks per week/4 or more drinks per week), sedentary lifestyle (yes/no), and depression status (score ≥ 6/<6). Means p < 0.01. Adjust covariates including: age, sex, living status (with family/single), smoking status (current or past/never), alcohol consumption (0 -3 drinks per week/≥4 drinks per week), sedentary lifestyle (yes/no), and depression status (score ≥ 6/<6). Abbreviation: AO-abdominal obesity (waist circumference, ≥90 cm for men and ≥80 cm for women), HT-hypertension (systolic BP, ≥130, diastolic BP, ≥85 mmHg, or the use of antihypertensive agents); HDL-C-low serum HDL-C (≤40 mg/dl for men and ≤50 mg/dl for women), HTG-hypertriglyceremia (TG, ≥150 mg/dl), HG-hyperglycemia (fasting plasma glucose, ≥100 mg/dl or the use of anti-hyperglycemic agents). 
Discussion
In this cross-section study, we found that difficulty falling asleep (DFA) increased the risk of MetS in the elderly from a northern Taiwanese community (OR = 1.42, 95% CI: 1.09 -1.86, P = 0.01). According to a prospective American study published in 2010 (middle-aged adults in community) that found DFA increased the risk of MetS by 80%, even after adjusting for demographic, psychosocial, and lifestyle characteristics [14] . These results raise the possibility that clinical insomnia complaints may be a causal risk factor for cardiometabolic dysfunction in adult. However, this study did not address this issue in an elderly population. Our previous study proved that DFA and unhealthy personsal sleep hygiene increased the number of MetS risk factors [20] , and another goal that provides data regarding the impact of common insomnia problems on the risk factors of MetS among the elderly population in northern Taiwan in this paper. Indeed, our data suggest that DFA, which may be an isolated insomnia disturbance, or a symptom related to any one of several sleep disorders, increased the risk for the MetS; but, the syndromic definition of insomnia was unrelated to MetS. Other insomnia symptoms, such as difficulty staying sleep, non-refreshing sleep, or frequent waking from sleep or dreamy, were independent of MetS even after accounting for the influence of insomnia duration. The results was partially mimic with previous paper, but in our study we did not focus on the snoring symptom which was found in another study, inclunding loud snoring more than doubled the risk of developing the metabolic syndrome and also predicted specific metabolic abnormalities (hyperglycemia and low high-density lipoprotein cholesterol) [14] . In our study, we focused on subjective insomnia symptoms, snorning symptom was belong to objective description which need be observated by roomates.
Prolonged sleep latency and short sleep duration may reflect a state of inappropriate arousal ("hyperarousal") due to an overactivation of stress system functions [28] - [30] , these physical changes have been implicated in the pathophysiology of insulin resistance and MetS. Evidence suggests that DFA is associated with the activation of transcription factor (NF)-kB, which plays a critical role in cellular inflammatory signaling [29] - [31] . This pathway leading to increased inflammatory response may link DFA with the development of the MetS, diabetes and other chronic diseases [32] . We speculate that pathways linking these insomnia symptoms with metabolic dysregulation might be due to sympathetic activation and increased inflammatory response [14] .
Moreover, our findings link DFA and frequent waking from sleep or dreamy with an increased risk of abdominal obesity. DFA was also correlated with the increased risk of hyperglycemia and high triglyceride, and difficulty staying sleep increased the risk of hypertension. Previous analysis shows that experimental sleep deprivation, short sleep duration, and persistent insomnia are associated with increased blood pressure and increased risk of hypertension, even after controlling for other risk factors [30] [33] . Poor sleep quantity, including longer sleep latency and inappropriate sleep duration increased the risk of abnormal body weight gain [34] and central obesity [35] [36] . In the Japanese study, women getting fewer than 6 hours of sleep on a regular basis had higher triglycerides and lower HDL-cholesterol than those getting 6 to 7 hours of sleep a night. Many of those men and women who slept fewer than 6 hours also reported in the study that they skipped meals, ate out once or more per day, and/or experienced high levels of psychological stress [37] .
In another 2-year prospective study of Japanese local residents (2005) (2006) (2007) , a total of 497 residents participated in this survey living in a rural community, the result showed that DFA is a risk factor for hyperglycemia (OR = 5.27, 95% CI: 1.48 -18.77, p = 0.01) [38] . Several studies have revealed that insomnia increases the blood catecholamines and cortisol concentration and insulin resistance [39] [40] . Previous epidemiological cross-sectional studies and several prospective studies in Western countries mentioned that many sleep symptoms, such as DFA, difficulty in maintaining sleep , and remaining alert, is higher in patients with diabetes [41] - [43] .
Recent studies have revealed that depression could be a confounding factor in the association between hyperglycemia and sleep disorders [44] . In our study, depression status was used as a covariate.
These insomnia symptoms, including DFA, difficulty staying sleep, and frequent waking from sleep or dreamy increased the odds ratio of risk factors. Evaluating insomnia symptoms can help identify individuals at risk for MetS. The lack of a relationship between insomnia syndrome and MetS may have important treatment implications, as worries about the health consequences of insomnia are a key risk factor in the disorder [45] . Recent evidence suggests that the presence of insomnia in conjunction with a physiologic indicator of disease severity strongly and significantly predicts hypertension risk, suggesting that different symptoms of insomnia may represent a higher threshold of risk, and this may be relevant in the prediction of cardiovascular outcomes [46] . An incomplete cross-sectional survey is a limitation of this study. We were only able to assess the aging population of a particular region of the northern metropolitan area, and this population may not be representative of the entire elderly population. The prevalence of MetS might be underestimated for some elderly individuals who may go to the medical center to receive physical examinations on their own, as they might pay more attention to their health than other elderly. The specific risk factors assessed in this study may have been found in the elderly population that has access to medical treatment and could be regarded as warranting intervention. Thus, these treated individuals would be precluded from our study population.
Conclusion
Our study provides evidence to support the relationship between commonly reported insomnia symptomsincluding difficulty falling asleep, difficulty staying sleep, and frequent waking from sleep and dreamy-and the risk of the MetS. Insomnia syndrome, defined using the Chinese version of the Athens Insomnia Scale (CAIS) as diagnostic criteria, was not a risk factor for metabolic syndrome. Given that in the general elderly population insomnia complaints are considerably more prevalent than either insomnia or obstructive sleep apnea syndromes, these findings have far-reaching implications for public health. This is particularly important given the epidemic levels of obesity and its associated cardiometabolic consequences, which are associated with insomnia complaints. These findings reflect the utility of assessing for common insomnia complaints in routine clinical practice, as individuals that report such insomnia-associated symptoms may be at elevated risk for the development of MetS.
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